OCUGEN, INC. Severance Costs
OCUGEN, INC. (OCGN) reported Severance Costs of $100.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2021-11-09
- OCUGEN, INC. severance costs for the quarter ending 2021-09-30 was $100.00K, a 50.00% decline year-over-year.
- OCUGEN, INC. severance costs for the quarter ending 2021-06-30 was $200.00K.
- OCUGEN, INC. severance costs for the quarter ending 2021-03-31 was $300.00K.
- OCUGEN, INC. severance costs for the quarter ending 2020-09-30 was $200.00K.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month |
|---|---|---|---|
| 2021-09-30 | $100.00K 10-Q · filed 2021-11-09 | $300.00K derived: sum of 2 quarters · filed 2021-11-09 | $600.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $200.00K 10-Q · filed 2021-08-06 | $500.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $300.00K 10-Q · filed 2021-05-07 | ||
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-09 | $200.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |